Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Scientific Reports|April 22, 2017
Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeysMario Losen, Aran F Labrijn, Vivianne H van Kranen-Mastenbroek, et al.
Scientific Reports|March 22, 2019
Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer's disease mouse modelJeroen Bogie, Cindy Hoeks, Melissa Schepers, et al.
Autoimmunity Reviews|November 12, 2018
Characterization of the thymus in Lrp4 myasthenia gravis: Four casesInga Koneczny, Dorit Rennspiess, Florit Marcuse, et al.
Journal of Autoimmunity|December 15, 2016
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patientsInga Koneczny, Jo A A Stevens, Anna De Rosa, et al.
Molecular Therapy. Nucleic Acids|June 20, 2022
Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patientsMaria Calderon-Dominguez, Eva Trejo-Gutierrez, Almudena González-Rovira, et al.
Alzheimer'S Research & Therapy|February 18, 2021
CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's diseaseSimone M Crivelli, Qian Luo, Jo A A Stevens, et al.
Viruses|August 10, 2021
Evaluation of ELISA-Based Multiplex Peptides for the Detection of Human Serum Antibodies Induced by Zika Virus Infection across Various CountriesMaria Del Pilar Martinez Viedma, Stephen Panossian, Kennedy Gifford, et al.
Frontiers in Neurology|August 4, 2025
Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptomsNikita A van de Burgt, Laila Kulsvehagen, Marina Mané-Damas, et al.
Blood Advances|February 9, 2021
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trialCatia Simoes, Bruno Paiva, David Martínez-Cuadrón, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 26, 2016
An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptakeGerard H Bode, Gregory Coué, Christian Freese, et al.
Pageof 20